Reaction profile

The FDA adverse-event record for diabetic ketonuria

265 FDA adverse-event reports reference diabetic ketonuria (VeDDRA 2054). Plate codes and volume neighbourhood below; species, breeds, and drugs follow.

#909 of 2,481
by report volume (all reactions)
265
reports citing this reaction
28.3%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Diabetic ketonuria has 265 reports now versus 265 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Diabetic ketonuria changes

FDA AER · VeDDRA plate

Code 2054 VOL-LOW

VOL-LOW · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-LOW 265 reports
  • DEATH-HOT 28.3%
  • MID-PACK #909/2481
  • PHOTO-FINISH Injection site warmth
  • SPECIES-DOG Dog · 209
  • DRUG-LEAD Trilostane · 79
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Injection site warmth (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Report-volume neighbourhood around Diabetic ketonuria

Highest and lowest poles plus nearest volume peers, not a full 2,500-reaction corpus board reprint.

Vomiting · highest174348Diabetic ketonuria · this re…265Injection site warmth · near265Prolonged one stage p… · near265Increased coagulation… · near264Hyperaemic mucous mem… · near263Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Diabetic ketonuria

Diabetic ketonuria: high death-coded share in the FDA AER plate

Signature read: 75 death-coded reports is a heavy tail count for Diabetic ketonuria in the CVM extract. Report volume sits in the middle third of the reaction corpus. Death-coded share is upper-third: 75 of 265 reports (28.3% of named reports). Nearest volume peer: Injection site warmth (±0 reports). Lead species Dog (209). Lead co-reported drug Trilostane (79).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 209
Cat 56

Breeds Most Affected

Domestic Shorthair 28
Crossbred Canine/dog 25
Retriever - Labrador 21
Chihuahua 12
Terrier - Yorkshire 11
Shih Tzu 11
Maltese 9
Domestic (unspecified) 8
Terrier (unspecified) 8
Domestic Longhair 7

Associated Drugs

Trilostane 79
Insulin Injectable Vial 31
Insulin 23
Carprofen 19
Bexagliflozin 18
Milbemycin Oxime + Spinosad 17
Maropitant Citrate 16
Recombinant Human Insulin 16
Famotidine 12
Cyclosporine 10
Moxidectin 9
Prednisone 9
Oclacitinib Maleate 8
Velagliflozin Proline Monohydrate 8
Gabapentin 7
Spinosad 6
Cefovecin 6
Buprenorphine 6
Methylprednisolone Acetate 5
Porcine Insulin 5

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Diabetic ketonuria, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar death-coded share

Nearest other reactions by death-coded share (28.3% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Diabetic ketonuria (#909 of 2,481 by report volume); death-coded 28.3%. PlainBreed reaction plate · death-coded report count stamp 75 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →